Calumet (CLMT) announced that Jennifer Straumins, a member of the company’s Board of Directors, has informed the Board of her decision not to seek re-election and to retire at the end of her current term, which expires at the company’s 2026 Annual Meeting of Stockholders. Straumins has served on the Board since July 2024, previously served on the board of Calumet GP, LLC from February 2021 to July 2024, and was also an employee of the Partnership for 13 years. Straumins currently serves on the Board’s Strategy and Growth and Risk Committees.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLMT:
- Calumet Completes Senior Notes Offering to Enhance Liquidity
- Calumet Prices New Senior Notes to Refinance Credit Facility
- Calumet Specialty Products Plans Additional Senior Notes Offering
- Calumet price target raised to $34 from $24 at Goldman Sachs
- Calumet Specialty Products Balances Big Gains and Headwinds